DESF
AQ109206
Phase 2 small_molecule completed
Quick answer
DESF for Allergic Reaction is a Phase 2 program (small_molecule) at Aquestive Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aquestive Therapeutics
- Indication
- Allergic Reaction
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed